fashion -WSS

fashion

author：knowledge 2025-08-29 19:58:57 - browse：721

As a new class of diabetes and obesity medications has soared in popularity, so have the online outlets built to get them in the hands of patients. A new analysis of claims data from Trilliant Health suggests that collectively, telehealth companies — in particular, cash-pay options that market directly to consumers — could account for many of the patients with insurance claims for GLP-1 prescriptions in 2022.

Direct-to-consumer telehealth companies have offered an easier on-ramp for many patients to access prescriptions for a variety of conditions. And since the first GLP-1s were approved for obesity — promising up to 15% weight loss — many of those companies have capitalized on the approvals and surging demand to launch new weight loss businesses. Companies including Calibrate and Ro claim to have reached tens and hundreds of thousands of patients with their weight loss medication programs.

Collectively, their reach may be even larger. The Trilliant Health analysis, conducted on behalf of STAT, offers an early glimpse of the foothold those businesses have gained in GLP-1 prescribing. In a nationwide claims database of more than 300 million patients using both commercial and federal insurance, Trilliant Health found about 3.6 million people with a prescription claim for a GLP-1 — semaglutide, tirzepatide, or injectable liraglutide without insulin — in 2022. To determine where each patient may have gotten those prescriptions, they looked for a medical visit claim within three days of a prescription claim for a GLP-1 — the visit where the script was likely written. But they only found a matching visit for 53% of patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
Next article： What we need to know about Arena Bioworks

focus

WSS

General Catalyst, Summa Health deal will turn on physician buy

Apple Vision Pro: A first look at health apps on the new VR headset

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

A $475,000 price tag for a new cancer drug: crazy or meh?

Blinken talks high

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

explore

fashion

hotspot

Affirmative action in medical school literally saved lives

Sickle cell gene therapy cures need to be accessible in Africa

How one medical school became remarkably diverse

EU fines Illumina $475 million over Grail acquisition

Guidelines to prevent youth baseball injuries need more muscle

One Duchenne patient's bittersweet hope for new treatment

Novavax promises a turnaround & Lilly roils the obesity market

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Women's World Cup brings attention to abuse in soccer

explore

Novo Nordisk to expand supply of Wegovy for U.S. patients

Woodcock on FDA’s accelerated approval and her next chapter

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Even great ERs can’t make up for American health disparities

Quicker fix for pulse oximeters urged during FDA public meeting

The real point of Kenneth Smith’s execution by nitrogen gas

entertainment

hotspot

focus

focus